11/26/2012. Implementation of Florida s PDMP. Disclosure

Size: px
Start display at page:

Download "11/26/2012. Implementation of Florida s PDMP. Disclosure"

Transcription

1 Implementation of Florida s PDMP Rebecca R. Poston Program Manager December 1, 2012 Disclosure I have no vested interest in or affiliation with any corporate organizations offering financial support or grant money for this continuing education program, or any affiliation with any organization whose philosophy could potentially bias my presentation. 1

2 OBJECTIVES Provide overview of Florida s Prescription Drug Monitoring Program regulations Discuss data reporting requirements Demonstrate health care practitioner registration Demonstrate health care practitioner Query~ Patient Advisory Report Discuss outcomes BACKGROUND The purpose of the PDMP is to provide information collected in the database to health care practitioners to guide their clinical decisions in prescribing and dispensing these highly-abused prescription drugs. 2

3 DEFINITIONS Section (1), F.S.: A dispenser means a pharmacy, a dispensing pharmacist, or a dispensing health care practitioner. A health care practitioner means any practitioner who is subject to licensure or regulation by the department under chapters 458, 459, 461, 462, 464, 465, or 466, F.S. DEFINITIONS CONTINUED Section (1), F.S.: Administer means the direct application of a controlled substance, whether by injection, inhalation, ingestion, or any other means, to the body of a person or animal. REPORTING REQUIREMENTS Pharmacy and dispensing practitioners must report within 7 days of dispensing a controlled substance in schedules II, III and IV to an individual Mandatory reporting began September 1, 2011 E-FORCSE requested dispensers report retroactive data from December 1, 2010 >53 MILLION records in database. 3

4 REPORTED INFORMATION Patient Demographics Date of Birth Gender Prescriber Demographics DEA Number NPI Number State License Number Pharmacy DEA Number Rx Number Date written, date filled Refill Number Drug Name Strength Dosage Form Quantity Payment Type CS INFORMATION NOT REPORTED If administered directly to a patient during that particular treatment session; If administered to a patient receiving care in a hospital or emergency room, nursing home, ambulatory surgical center, hospice, intermediate care facility for developmentally disabled; If administered or dispensed in the health care system of the Department of Corrections; If administered or dispensed to a patient less than 16 years of age; If dispensed one-time 72-hour re-supply to a patient; If prescribed by a health care practitioner; or If prescribed or dispensed by a health care practitioner in a DOD/VA facility. PENALTY FOR NON-COMPLIANCE A health care practitioner who willfully and knowingly fails to report the dispensing of a controlled substance as required by section , F.S., commits a first degree misdemeanor. 4

5 AUTHORITY TO ACCESS THE DATABASE Section (7)(b), F.S.: A pharmacy, prescriber, or dispenser shall have access to information in the prescription drug monitoring program s database which relates to a patient of that pharmacy, prescriber, or dispenser for the purpose of reviewing the patient s controlled substance prescription history. PUBLIC RECORD EXEMPTION Section , F.S., any person who willfully and knowingly violates this section of law by sharing confidential protected health information commits a felony of the third degree. ACCESSING THE RxSENTRY SITE RxSentry site: 5

6 Requesting an account Creating query requests Viewing query request status Generating reports Viewing patient records 6

7 LOGGING ON TO FL RxSENTRY User Name: newacct Password: welcome 7

8 Patient Advisory Report Request QUERY SITE Click Query Site Type in User ID Type in Password Click OK License # PDMP Menu 8

9 PRACTITIONER DISCLAIMER PRACTITIONER QUERY SCREEN PRACTITIONER PATIENT SELECTION 9

10 VIEW QUERY STATUS Approved/Queued- the query has been approved and is processing Approved/Done- the query has been approved, processed, and is available for viewing PATIENT ADVISORY REPORT 10

11 VIEW PATIENT ADVISORY REPORTS Open open the report for viewing and printing (if desired) Save save the report to a specific location for viewing and printing (if desired) at a later time. Cancel 11

12 PERFORMANCE MEASURES Outcome: Reduction of the rate of inappropriate use of prescription drugs through education and safety efforts Measure: The number of licensed prescribers, dispensers, and individuals authorized to conduct investigations that were trained in the use of the state's PDMP system. Controlled Substance Prescriptions Reported by Dispensers Number of Pharmacies / Dispensers who have reported to the PDMP 6,391 Number of prescription records reported to the PDMP 55,041,371 NUMBER OF PDMP REGISTERED USERS Healthcare Practitioners 18,385 Law Enforcement Officers 546 TOTAL 18,931 12

13 NUMBER OF PATIENT ADVISORY REPORT REQUESTS= 2.5 MILLION PERFORMANCE MEASURES Measure: The number of coroner reports that indicate controlled substance prescription drug use as the primary or contributing cause of death. 1 13

14 PERFORMANCE MEASURES Outcome: Reduction of the quantity of pharmaceutical controlled substances obtained by individuals attempting to engage in fraud and deceit. Measure: The number of individuals obtaining controlled substance prescriptions from X or more prescribers and X or more pharmacies in a 90 day period. 2 14

15 DOH RULEMAKING Rule 64K-1, Florida Administrative Code Rule Promulgation 64K Indicators of Controlled Substance Abuse System Enhancements Update User Profile 15

16 SYSTEM ENHANCEMENTS Interstate Data Exchange States Number of Prescriptions Issued by Florida Prescribers 2009 Alabama 116,000 Louisiana 16,000 North Carolina 48,000 South Carolina 28,000 Arizona 14,000 Vermont 1,700 Total 223,700 Future System Enhancements Integration into Clinical Workflows 16

17 Future System Enhancements Integration into Electronic Health Record Primary Care Practice Future System Enhancements Real Time Data Reporting Presentation Summary Reviewed Florida s Prescription Drug Monitoring Program regulations Discussed data reporting requirements Demonstrated health care practitioner registration Demonstrated health care practitioner Query~ Patient Advisory Report Discussed performance measures and program outcomes 17

18 Conclusion Physicians and pharmacists have queried 53 million records more than 2.3 million times to improve clinical decision making, help reduce diversion and abuse of controlled substances and to assist in curbing the prescription drug abuse epidemic in Florida. PDMP must become a routine part of every clinical practice not because it s mandated, but because it makes good clinical sense. Future of PDMP includes building integration into existing workflow and technology, interoperability of data between states, strengthening partnerships, and identifying sustainable funding. Questions How often does a pharmacy need to upload a or report dispensing information to the PDMP? a. 10 days b. 15 days c. 7 days d. Real time Questions True or False I am required to view my patient s specific controlled substance history prior to dispensing a controlled substance. 18

19 Questions What is the penalty for a health care practitioner that does not report their Schedule II-IV controlled substance dispensing data? a. Felony b. Misdemeanor Questions What is the penalty for disclosure of confidential information in the E-FORCSE database? a. Felony b. Misdemeanor Need Technical Assistance? Contact Health Information Designs, Inc. for Technical Support & Assistance: Phone: flpdmp-info@hidinc.com Website: 8:00 am 5:00 pm EST 19

20 Need Program Assistance? Contact E-FORCSE Program Staff for non-technical assistance Phone: Website: Rebecca Poston, Program Manager Erika Marshall, Program Operations Administrator and Outreach Director QUESTIONS? References 1. Medical Examiner s Commission, Drugs Identified in Deceased Persons by Florida Medical Examiners, 2011 Report, Florida Department of Law Enforcement available at Report_Final.aspx 2. Florida Department of Health, Prescription Drug Monitoring Program Annual Report 2012 available at on December 1,

Implementation of Florida s PDMP. Rebecca Poston Program Manager

Implementation of Florida s PDMP. Rebecca Poston Program Manager Implementation of Florida s PDMP Rebecca Poston Program Manager Disclaimer I have no relevant financial relationships or commercial interest in the content presented in this program. Learning Objectives:

More information

FACT SHEET FOR HEALTH CARE PRACTITIONERS

FACT SHEET FOR HEALTH CARE PRACTITIONERS Florida s Prescription Drug Monitoring Program http://www.e-forcse.com FACT SHEET FOR HEALTH CARE PRACTITIONERS The Florida Prescription Drug Monitoring Program (PDMP), known as E-FORCSE (Electronic- Florida

More information

Prescription Drug Abuse Florida s Health Crisis

Prescription Drug Abuse Florida s Health Crisis Prescription Drug Abuse Florida s Health Crisis Overview Florida has been the epicenter for the diversion and abuse of prescription drugs. Prescription drugs killed almost 7 Floridians per day after an

More information

2010-2011 Prescription Drug Monitoring Program Annual Report

2010-2011 Prescription Drug Monitoring Program Annual Report 2010-2011 Prescription Drug Monitoring Program Annual Report Prescription Drug Monitoring Program E-FORCSE 4052 Bald Cypress Way, Bin C-16 Tallahassee, FL 32399 (850) 245-4444 X 3700 December 1, 2011 Prescription

More information

REFERENCE ACTION ANALYST STAFF DIRECTOR or BUDGET/POLICY CHIEF. 1) Health Quality Subcommittee 9 Y, 2 N Poche O'Callaghan SUMMARY ANALYSIS

REFERENCE ACTION ANALYST STAFF DIRECTOR or BUDGET/POLICY CHIEF. 1) Health Quality Subcommittee 9 Y, 2 N Poche O'Callaghan SUMMARY ANALYSIS HOUSE OF REPRESENTATIVES STAFF ANALYSIS BILL #: HB 1381 Prescription Drug Monitoring Program SPONSOR(S): Davis TIED BILLS: IDEN./SIM. BILLS: REFERENCE ACTION ANALYST STAFF DIRECTOR or BUDGET/POLICY CHIEF

More information

Training Guide for Florida Practitioners and Pharmacists. Florida Department of Health Prescription Drug Monitoring Program

Training Guide for Florida Practitioners and Pharmacists. Florida Department of Health Prescription Drug Monitoring Program Training Guide for Florida Practitioners and Pharmacists Florida Department of Health Prescription Drug Monitoring Program January 2015 Contents Contents 1 Program Overview... 2 2 Document Overview...

More information

Training Guide for Florida Practitioners and Pharmacists

Training Guide for Florida Practitioners and Pharmacists Training Guide for Florida Practitioners and Pharmacists Florida Department of Health Prescription Drug Monitoring Program March 2014 Note This document is periodically updated. Please refer to the Florida

More information

Florida. http://www.floridahealth.gov/statistics-and-data/e-forcse/index.html e-forcse@flhealth.gov. Contact Information. Fax: Email: Statistics

Florida. http://www.floridahealth.gov/statistics-and-data/e-forcse/index.html e-forcse@flhealth.gov. Contact Information. Fax: Email: Statistics PDMP name: Agency Responsible: Agency Type: PDMP Website: PDMP Email: Florida Department of Health Department of Health Florida http://www.floridahealth.gov/statistics-and-data/e-forcse/index.html e-forcse@flhealth.gov

More information

Achieving Better Care by Monitoring All Prescriptions (ABC-MAP) Act 191 of 2014 Board Meeting April 8, 2015

Achieving Better Care by Monitoring All Prescriptions (ABC-MAP) Act 191 of 2014 Board Meeting April 8, 2015 Achieving Better Care by Monitoring All Prescriptions (ABC-MAP) Act 191 of 2014 Board Meeting April 8, 2015 ABC-MAP Board Meeting Agenda Prescription Drug Monitoring Background ABC-MAP Overview Board Responsibilities

More information

Alaska Prescription Drug Monitoring Program

Alaska Prescription Drug Monitoring Program Alaska 1. What is a PDMP? PDMP stands for. This is a commonly used term for the programs implemented by various states to monitor the dispensing of controlled substances within their borders. For this

More information

Training Guide for Government Agencies and Healthcare Administration

Training Guide for Government Agencies and Healthcare Administration Training Guide for Government Agencies and Healthcare Administration Pharmacy Examining Board Wisconsin Department of Safety and Professional Services May 2013 Contents Contents 1 Document Overview...

More information

Controlled Substances Prescription Monitoring Program. Dean Wright, RPh Arizona State Board of Pharmacy

Controlled Substances Prescription Monitoring Program. Dean Wright, RPh Arizona State Board of Pharmacy Controlled Substances Prescription Monitoring Program Dean Wright, RPh Arizona State Board of Pharmacy Controlled Substances Prescription Monitoring Program Arizona s Forty-eighth Legislature passed H.B.

More information

FREQUENTLY ASKED QUESTIONS

FREQUENTLY ASKED QUESTIONS FREQUENTLY ASKED QUESTIONS for the Revised: February 2014 NEW YORK STATE DEPARTMENT OF HEALTH Bureau of Narcotic Enforcement 1-866-811-7957 www.health.ny.gov/professionals/narcotic Online PMP Q: What is

More information

Training Guide for Delaware Practitioners and Pharmacists Delaware Division of Professional Regulation Prescription Monitoring Program

Training Guide for Delaware Practitioners and Pharmacists Delaware Division of Professional Regulation Prescription Monitoring Program Training Guide for Delaware Practitioners and Pharmacists Delaware Division of Professional Regulation Prescription Monitoring Program August 2014 v1.7 Contents Contents 1 Document Overview... 1 Purpose

More information

Frequently Asked Questions

Frequently Asked Questions This document provides answers to some common questions regarding the reporting of controlled substances to the New Hampshire (PDMP) database. A list of the questions answered in this document is provided

More information

PDMP User s Guide. Oregon Health Authority Prescription Drug Monitoring Program

PDMP User s Guide. Oregon Health Authority Prescription Drug Monitoring Program Oregon Health Authority Prescription Drug Monitoring Program December 2015 Contents Contents 1 Document Overview... 1 Purpose and Contents... 1 RxSentry Update... 1 2 System Overview... 3 About the RxSentry

More information

Frequently Asked Questions

Frequently Asked Questions This document provides answers to some common questions regarding the reporting of controlled substances to the Hawaii (HI PDMP) database. A list of the questions answered in this document is provided

More information

Oregon Prescription Drug Monitoring Program. Terms & Conditions of Account Use Agreement. Statutory Authority:

Oregon Prescription Drug Monitoring Program. Terms & Conditions of Account Use Agreement. Statutory Authority: Oregon Prescription Drug Monitoring Program Terms & Conditions of Account Use Agreement Statutory Authority: The Oregon Health Authority (OHA) was given authority under ORS 431.962 to establish and maintain

More information

CURES Prescription Drug Monitoring Program

CURES Prescription Drug Monitoring Program California Department of Justice CURES Prescription Drug Monitoring Program February, 2013 The mission of the California Prescription Drug Monitoring Program (PDMP) is to eliminate pharmaceutical drug

More information

Dispenser s Implementation Guide

Dispenser s Implementation Guide Alabama Department of Public Health Prescription Drug Monitoring Program October 2014 This document is formatted for duplex printing. This page intentionally left blank. Copyright 2009-2014 Health Information

More information

Colorado Prescription Drug Monitoring Program. Department of Regulatory Agencies Division of Professions and Occupations State Board of Pharmacy

Colorado Prescription Drug Monitoring Program. Department of Regulatory Agencies Division of Professions and Occupations State Board of Pharmacy Colorado Prescription Drug Monitoring Program Department of Regulatory Agencies Division of Professions and Occupations State Board of Pharmacy DORA is dedicated to preserving the integrity of the marketplace

More information

2014 Legislative Session. Florida Pharmacy Laws(Statutes) Disclosure. Objectives. 465.014 (1) Pharmacy Technician. Pharmacy Law Update 4/22/2014

2014 Legislative Session. Florida Pharmacy Laws(Statutes) Disclosure. Objectives. 465.014 (1) Pharmacy Technician. Pharmacy Law Update 4/22/2014 2014 Legislative Session Pharmacy Law Update George Malone, PharmD Chair, FSHP Legal & Regulatory Affairs Council HB 323/SB 278 HB 7077/SB 662 HB 859/SB 962 SB 7016 HQS1 Relating to Pharmacy Technicians

More information

Query and Reports Tutorial. Minnesota Board of Pharmacy Prescription Monitoring Program

Query and Reports Tutorial. Minnesota Board of Pharmacy Prescription Monitoring Program Minnesota Board of Pharmacy Prescription Monitoring Program August 2015 Contents Contents 1 Document Overview... 1 Purpose and Contents... 1 RxSentry Update... 1 2 Accessing RxSentry... 3 Request an Account...

More information

Practitioner s Training Guide. North Carolina Department of Health and Human Services Controlled Substance Reporting System

Practitioner s Training Guide. North Carolina Department of Health and Human Services Controlled Substance Reporting System North Carolina Department of Health and Human Services Controlled Substance Reporting System August 2014 Contents Contents 1 Document Overview... 1 Purpose and Contents... 1 2 System Overview... 2 About

More information

NOTICE REQUIREMENTS FOR PRESCRIPTION MONITORING PROGRAMS

NOTICE REQUIREMENTS FOR PRESCRIPTION MONITORING PROGRAMS NOTICE REQUIREMENTS FOR PRESCRIPTION MONITORING PROGRAMS This project was supported by Grant No. G1299ONDCP03A, awarded by the Office of National Drug Control Policy. Points of view or opinions in this

More information

Pill Mills, Non-Therapeutic Drug Use, and Prescription Drug Monitoring What to Look for During Investigations

Pill Mills, Non-Therapeutic Drug Use, and Prescription Drug Monitoring What to Look for During Investigations Pill Mills, Non-Therapeutic Drug Use, and Prescription Drug Monitoring What to Look for During Investigations ffrey J. Mesaros, PharmD, JD ice Chair Florida Board of Pharmacy ay 21, 2013 Learning Objectives

More information

Table of Contents. User Request for Access... 3. User Login... 3. Upload a Data File... 4

Table of Contents. User Request for Access... 3. User Login... 3. Upload a Data File... 4 Table of Contents User Request for Access... 3 User Login... 3 Upload a Data File... 4 Add Patient Records Direct Dispenser Users... 5 Pharmacy... 8 Search for Patient Records... 10 Search for Error Records...

More information

2014 Legislative Session. Disclosure. Florida Pharmacy Laws(Statutes) Objectives. 465.014 (1) Pharmacy Technician. FL Pharmacy Law Update May 24, 2014

2014 Legislative Session. Disclosure. Florida Pharmacy Laws(Statutes) Objectives. 465.014 (1) Pharmacy Technician. FL Pharmacy Law Update May 24, 2014 2014 Legislative Session FL Pharmacy Law Update May 24, 2014 Norman Tomaka, MS, BS Pharm, FAPhA Board of Directors, FSHP HB 323/SB 278 HB 7077/SB 662 HB 859/SB 962 SB 7016 HQS1 Relating to Pharmacy Technicians

More information

CHAPTER 2010-211. Committee Substitute for Committee Substitute for Senate Bill No. 2272 and Committee Substitute for Senate Bill No.

CHAPTER 2010-211. Committee Substitute for Committee Substitute for Senate Bill No. 2272 and Committee Substitute for Senate Bill No. CHAPTER 2010-211 Committee Substitute for Committee Substitute for Senate Bill No. 2272 and Committee Substitute for Senate Bill No. 2722 An act relating to controlled substances; amending s. 456.037,

More information

Bureau of Justice Assistance Harold Rogers Prescription Drug Monitoring Program National Meeting 9/23/2014

Bureau of Justice Assistance Harold Rogers Prescription Drug Monitoring Program National Meeting 9/23/2014 Bureau of Justice Assistance Harold Rogers Prescription Drug Monitoring Program National Meeting 9/23/2014 Jeanne Tuttle, R.Ph. National Pharmacist Program Managers Pharmacy Benefits Management Services

More information

Delaware. Division of Professional Regulation, Office of Controlled Substances Professional Licensing Agency

Delaware. Division of Professional Regulation, Office of Controlled Substances Professional Licensing Agency PDMP name: Agency Responsible: Agency Type: PDMP Website: PDMP Email: Delaware Division of Professional Regulation, Office of Controlled Substances Professional Licensing Agency Nettesheim, Samantha -

More information

South Dakota Prescription Drug Monitoring Program (SD PDMP) Learning Objectives

South Dakota Prescription Drug Monitoring Program (SD PDMP) Learning Objectives South Dakota Prescription Drug Monitoring Program (SD PDMP) SD Academy of Physician Assistants Summer/Fall CME Conference September 6, 2012 Ron Huether, RPh, SD PDMP Kari Shanard Koenders, RPh, PDMP Director

More information

Massachusetts. Contact Information. Statistics. Technological Capabilities

Massachusetts. Contact Information. Statistics. Technological Capabilities PDMP name: Agency Responsible: Agency Type: PDMP Website: PDMP Email: Vacant - Assistant Director 99 Chauncy Street Boston MA 02111 Office: (617) 753-8104 Fax: (617) 524-8062 Email: ASAP Versions Accepted

More information

New Mexico. Contact Information. Email: Statistics. Technological Capabilities

New Mexico. Contact Information. Email: Statistics. Technological Capabilities PDMP name: Agency Responsible: Agency Type: PDMP Website: PDMP Email: Vacant - PMP Director 5500 San Antonio Drive NE Albuquerque NM 87109 Office: (505) 222-9837 Fax: (505) 222-9845 Email: @state.nm.us

More information

DC DEPARTMENT OF HEALTH Pharmaceutical Procurement and Distribution Pharmaceutical Warehouse. DC Health Care Safety Net ALLIANCE PROGRAM

DC DEPARTMENT OF HEALTH Pharmaceutical Procurement and Distribution Pharmaceutical Warehouse. DC Health Care Safety Net ALLIANCE PROGRAM DC DEPARTMENT OF HEALTH Pharmaceutical Warehouse DC Health Care Safety Net ALLIANCE PROGRAM OPERATIONAL PROTOCOLS Operational protocols for the DC Health Care Alliance program through the DOH Pharmaceutical

More information

2015 ANNUAL REVIEW OF PRESCRIPTION MONITORING PROGRAMS

2015 ANNUAL REVIEW OF PRESCRIPTION MONITORING PROGRAMS 2015 ANNUAL REVIEW OF PRESCRIPTION MONITORING PROGRAMS Research current through September 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy.

More information

Pain Management Regulations Affect More Than Pain Management Specialists January 2012. Of counsel to

Pain Management Regulations Affect More Than Pain Management Specialists January 2012. Of counsel to Pain Management Regulations Affect More Than Pain Management Specialists January 2012 LINDA A. KEEN MSN, JD, LHCRM LAW OFFICE OF LINDA A. KEEN P.A. TALLAHASSEE, FL Of counsel to Pain Management Regulations

More information

Washington. Contact Information. Email: Statistics. Technological Capabilities

Washington. Contact Information. Email: Statistics. Technological Capabilities PDMP name: Agency Responsible: Agency Type: PDMP Website: PDMP Email: Baumgartner, Chris - Director P O Box 47852 Olympia WA 98504-7852 Office: (360) 236-4806 Fax: (360) 236-2901 Email: Washington Washington

More information

Louisiana Administrative Code. Title 46 Professional and Occupational Standards. Part LIII: Pharmacists

Louisiana Administrative Code. Title 46 Professional and Occupational Standards. Part LIII: Pharmacists Chapter 17. Institutional Pharmacy Louisiana Administrative Code Title 46 Professional and Occupational Standards Subchapter A. General Requirements Part LIII: Pharmacists 1701. Cross References A. For

More information

Manual of Instructions

Manual of Instructions NEW YORK STATE DEPARTMENT OF HEALTH OFFICIAL NEW YORK STATE PRESCRIPTION PROGRAM ELECTRONIC DATA TRANSMISSION Manual of Instructions New York State Department of Health Bureau of Narcotic Enforcement 433

More information

Georgia. Contact Information. Office: Fax: Email: Statistics. Technological Capabilities

Georgia. Contact Information. Office: Fax: Email: Statistics. Technological Capabilities PDMP name: Agency Responsible: Agency Type: PDMP Website: PDMP Email: Higgins, Ronnie - Special Agent 40 Pryor St SW, Ste 2000 Atlanta GA 30303 Office: (404) 656-5100 Fax: (404) 651-8210 Email: rhiggins@gdna.ga.gov

More information

New Jersey. Contact Information. Statistics. Technological Capabilities

New Jersey. Contact Information. Statistics. Technological Capabilities PDMP name: Agency Responsible: Agency Type: PDMP Website: PDMP Email: Mielo, James - Administrator 124 Halsey St Newark NJ 07102 Office: (973) 273-8010 Fax: Email: NJPMRS mieloj@dca.lps.state.nj.us ASAP

More information

Maryland. Department of Health and Mental Hygiene, Alcohol and Drug Abuse Administration Substance Abuse Agency

Maryland. Department of Health and Mental Hygiene, Alcohol and Drug Abuse Administration Substance Abuse Agency PDMP name: Agency Responsible: Agency Type: PDMP Website: PDMP Email: Jackson, Kate - PDMP Manager 55 Wade Ave Catonsville MD 21228 Office: (410) 402-8609 Fax: (410) 402-8601 Email: Maryland Department

More information

South Carolina. South Carolina Department of Health and Environmental Control Department of Health http://www.scdhec.gov/scripts scripts@dhec.sc.

South Carolina. South Carolina Department of Health and Environmental Control Department of Health http://www.scdhec.gov/scripts scripts@dhec.sc. PDMP name: Agency Responsible: Agency Type: PDMP Website: PDMP Email: Frick, Christie J. - Director (Rph) 2600 Bull St Columbia SC 29201 Office: (803) 896-0688 Fax: (803) 896-0686 Email: SCRIPTS frickcj@dhec.sc.gov

More information

Montana. Contact Information. Email: Statistics. Technological Capabilities

Montana. Contact Information. Email: Statistics. Technological Capabilities PDMP name: Agency Responsible: Agency Type: PDMP Website: PDMP Email: Montana Board of Pharmacy Pharmacy Board www.mpdr.mt.gov dlibsdmpdr@mt.gov Peterson, Donna - Program Manager PO Box 200513 Helena MT

More information

State Advocacy Guide to Prescription Drug Monitoring Program Legislation and Regulations

State Advocacy Guide to Prescription Drug Monitoring Program Legislation and Regulations State Advocacy Guide to Prescription Drug Monitoring Program Legislation and Regulations There is currently an epidemic of prescription opioid abuse, misuse and diversion in the U.S. Numerous federal,

More information

Prescribers required to check PDMP before first prescription for Controled Substances for new patient.

Prescribers required to check PDMP before first prescription for Controled Substances for new patient. State, District, or Territory Alabama Arizona Arkansas Colorado Connecticut Delaware Georgia Guam Criteria for Mandatory Enrollment or Query of PDMP Before renewing an Alabama Controlled Substances Certificate,

More information

Pharmacy Operations. Assisting the Pharmacist. Pharmacy Technician Training Systems Passassured, LLC

Pharmacy Operations. Assisting the Pharmacist. Pharmacy Technician Training Systems Passassured, LLC Pharmacy Operations Assisting the Pharmacist Pharmacy Technician Training Systems Passassured, LLC Pharmacy Operations, Assisting the Pharmacist PassAssured's Pharmacy Technician Training Program Pharmacy

More information

Arizona. Contact Information. Office: Fax: Email: Statistics. Technological Capabilities

Arizona. Contact Information. Office: Fax: Email: Statistics. Technological Capabilities PDMP name: Agency Responsible: Agency Type: PDMP Website: PDMP Email: Arizona State Board of Pharmacy Pharmacy Board Wright, Dean - Program Director P O Box 18520 Phoenix AZ 85005 Office: (602) 771-2744

More information

Second Annual Florida 2008 Electronic Prescribing Report

Second Annual Florida 2008 Electronic Prescribing Report Second Annual Florida 2008 Electronic Prescribing Report FLORIDA CENTER FOR HEALTH INFORMATION AND POLICY ANALYSIS AGENCY FOR HEALTH CARE ADMINISTRATION JANUARY 2009 Better Health Care for All Floridians

More information

EPCS FREQUENTLY ASKED QUESTIONS FOR ELECTRONIC PRESCRIBING OF CONTROLLED SUBSTANCES. Revised: January 2016

EPCS FREQUENTLY ASKED QUESTIONS FOR ELECTRONIC PRESCRIBING OF CONTROLLED SUBSTANCES. Revised: January 2016 FREQUENTLY ASKED QUESTIONS FOR ELECTRONIC PRESCRIBING OF CONTROLLED SUBSTANCES EPCS Revised: January 2016 NEW YORK STATE DEPARTMENT OF HEALTH Bureau of Narcotic Enforcement 1-866-811-7957 www.health.ny.gov/professionals/narcotic

More information

Pitfalls of Working in Family Medicine Presented by:

Pitfalls of Working in Family Medicine Presented by: Pitfalls of Working in Family Medicine Presented by: www.thehealthlawfirm.com Main Office: 1101 Douglas Avenue Altamonte Springs, Florida 32714 Phone: (407) 331-6620 Fax: (407) 331-3030 Website: www.thehealthlawfirm.com

More information

PROPOSED REGULATION OF THE STATE BOARD OF PHARMACY. LCB File No. R047-15. September 15, 2015

PROPOSED REGULATION OF THE STATE BOARD OF PHARMACY. LCB File No. R047-15. September 15, 2015 PROPOSED REGULATION OF THE STATE BOARD OF PHARMACY LCB File No. R047-15 September 15, 2015 EXPLANATION Matter in italics is new; matter in brackets [omitted material] is material to be omitted. AUTHORITY:

More information

PMP AWAR X E. User Support Manual V 1.2

PMP AWAR X E. User Support Manual V 1.2 PMP AWAR X E User Support Manual V 1.2 04/09/2014 1 Contents 1 What Is a Requestor?... 3 2 Registration... 3 2.1 Registration Process... 3 2.2 Registering as a Delegate... 7 2.3 Email Verification... 11

More information

Prescription Monitoring Programs: Creating a National Network

Prescription Monitoring Programs: Creating a National Network Prescription Monitoring Programs: Creating a National Network Danna E. Droz, JD, RPH PMP Liaison ddroz@nabp.net 847/391-4508 United States Drug Enforcement Administration National Conference on Pharmaceutical

More information

Colorado. Contact Information. Statistics. Technological Capabilities

Colorado. Contact Information. Statistics. Technological Capabilities PDMP name: Agency Responsible: Agency Type: PDMP Website: PDMP Email: Colorado State Board of Pharmacy Pharmacy Board http://www.hidinc.com/copdmp pdmpinqr@state.co.us Rivera, Janina - PDMP Administrator

More information

Idaho. Contact Information. Fax: (208) 334-3536 Email: Statistics. Technological Capabilities

Idaho. Contact Information. Fax: (208) 334-3536 Email: Statistics. Technological Capabilities PDMP name: Agency Responsible: Agency Type: PDMP Website: PDMP Email: Idaho Board of Pharmacy Pharmacy Board http://idaho.pmpaware.net pmp@bop.idaho.gov Anderson, Teresa - Program Information Coordinator

More information

How To Write An Eprescription In Dubai

How To Write An Eprescription In Dubai Page 1 of 6 patient medical records and eligibility available at the moment of prescribing and dispensing the medication. Serving the insured population in Dubai What is an e-prescription? It is the computer-based

More information

Illinois. Contact Information. Office: Fax: Email: Statistics. Technological Capabilities

Illinois. Contact Information. Office: Fax: Email: Statistics. Technological Capabilities PDMP name: Agency Responsible: Agency Type: PDMP Website: PDMP Email: Berberet, Craig - PMP Manager 401 N Fourth St, Rm 126 Springfield IL 62702 Office: (217) 558-0943 Fax: (217) 557-7975 Email: PIL Department

More information

HOUSE OF REPRESENTATIVES STAFF ANALYSIS REFERENCE ACTION ANALYST STAFF DIRECTOR. 1) Health Care Mitchell Collins 2) 3) 4) 5)

HOUSE OF REPRESENTATIVES STAFF ANALYSIS REFERENCE ACTION ANALYST STAFF DIRECTOR. 1) Health Care Mitchell Collins 2) 3) 4) 5) HOUSE OF REPRESENTATIVES STAFF ANALYSIS BILL #: HB 103 Medicinal Drug Prescriptions SPONSOR(S): Quinones TIED BILLS: IDEN./SIM. BILLS: SB 132 (i) REFERENCE ACTION ANALYST STAFF DIRECTOR 1) Health Care

More information

FREQUENTLY ASKED QUESTIONS FOR ELECTRONIC PRESCRIBING OF CONTROLLED SUBSTANCES

FREQUENTLY ASKED QUESTIONS FOR ELECTRONIC PRESCRIBING OF CONTROLLED SUBSTANCES FREQUENTLY ASKED QUESTIONS FOR ELECTRONIC PRESCRIBING OF CONTROLLED SUBSTANCES EPCS Revised: April 2015 NEW YORK STATE DEPARTMENT OF HEALTH Bureau of Narcotic Enforcement 1-866-811-7957 www.health.ny.gov/professionals/narcotic

More information

Subject: Health; prescription drugs; Vermont Prescription Monitoring 5 System

Subject: Health; prescription drugs; Vermont Prescription Monitoring 5 System 0 Page of S. Introduced by Senator Sears Referred to Committee on Date: Subject: Health; prescription drugs; Vermont Prescription Monitoring System Statement of purpose of bill as introduced: This bill

More information

Prescriptive Authority FAQ: Washington CRNAs

Prescriptive Authority FAQ: Washington CRNAs : Washington CRNAs This FAQ (Frequently Asked Questions) is maintained by. If you have comments or a question that is not answered here, please send it to wana1@comcast.net. DISCLAIMER: Please remember,

More information

ARKANSAS PRODUCTS: PRODUCT EXEMPTIONS: SALES LIMITS: SALES RESTRICTIONS:

ARKANSAS PRODUCTS: PRODUCT EXEMPTIONS: SALES LIMITS: SALES RESTRICTIONS: ARKANSAS PRODUCTS: Any product containing ephedrine, pseudoephedrine, or phenylpropanolamine or any of their salts, isomers, or salts of isomers, alone or in a mixture. (A.C.A. 5-64-212) PRODUCT EXEMPTIONS:

More information

Guam. Contact Information. Email: Statistics. Technological Capabilities

Guam. Contact Information. Email: Statistics. Technological Capabilities PDMP name: Agency Responsible: Agency Type: PDMP Website: PDMP Email: Naval, Cynthia L. - Planner IV 123 Chalan Kareta Mangilao GU 96913-6304 Office: (671) 735-7204 Fax: (671) 734-5556 Email: GPDMP Guam

More information

NH Laws / Rules Regarding Limited Retail Drug Distributors

NH Laws / Rules Regarding Limited Retail Drug Distributors NH Laws / Rules Regarding Limited Retail Drug Distributors 318:1, VII-a. "Limited retail drug distributor'' means a distributor of legend devices or medical gases delivered directly to the consumer pursuant

More information

Exceptions to the Rule: A Pharmacy Law Presentation. Objectives DISCLAIMER 10/16/2015

Exceptions to the Rule: A Pharmacy Law Presentation. Objectives DISCLAIMER 10/16/2015 Exceptions to the Rule: A Pharmacy Law Presentation Eric Roath, Pharm.D. Director of Professional Practice Michigan Pharmacists Association Objectives 1. Identify basic legal frameworks that govern the

More information

DIVISION OF MEDICAL QUALITY ASSURANCE BOARD OF PHARMACY 4052 BALD CYPRESS WAY, BIN #C-04 TALLAHASSEE, FLORIDA 32399-3254 (850) 245-4292

DIVISION OF MEDICAL QUALITY ASSURANCE BOARD OF PHARMACY 4052 BALD CYPRESS WAY, BIN #C-04 TALLAHASSEE, FLORIDA 32399-3254 (850) 245-4292 DIVISION OF MEDICAL QUALITY ASSURANCE BOARD OF PHARMACY 4052 BALD CYPRESS WAY, BIN #C-04 TALLAHASSEE, FLORIDA 32399-3254 (850) 245-4292 COMMUNITY PHARMACY PERMIT APPLICATION AND INFORMATION August 2012

More information

(1) Program monitors multiple schedules of medications (at least Schedules II-IV) (see below Section 3: Purpose)

(1) Program monitors multiple schedules of medications (at least Schedules II-IV) (see below Section 3: Purpose) ESSENTIAL ELEMENTS OF AN ELECTRONIC PRESCRIPTION MONITORING PROGRAM There currently is a wide variety of factors that characterize state electronic Prescription Monitoring Programs (PMPs), which originated

More information

Prince Edward Island Drug Information System. Privacy and Security Awareness Training

Prince Edward Island Drug Information System. Privacy and Security Awareness Training Prince Edward Island Drug Information System Privacy and Security Awareness Training Purpose of the DIS The purpose of the PEI Drug Information System is established in section two (2) of the Pharmaceutical

More information

Technical Assistance Guide. PDMP Suggested Practices to Ensure Pharmacy Compliance and Improve Data Integrity

Technical Assistance Guide. PDMP Suggested Practices to Ensure Pharmacy Compliance and Improve Data Integrity Technical Assistance Guide PDMP Suggested Practices to Ensure Pharmacy Compliance and Improve Data Integrity This project was supported by Grant No. 2011-PM-BX-K001 awarded by the Bureau of Justice Assistance.

More information

Prescription Drug Monitoring Programs

Prescription Drug Monitoring Programs Prescription Drug Monitoring Programs Montana State Fund 13 th Annual Medical Conference November 1, 2013 Peter Kreiner, Ph.D. PDMP Center of Excellence at Brandeis University Primary non-heroin opiates/synthetics

More information

Board of Pharmacy Legislative Update Allison M. Dudley, J.D. Executive Director Board of Pharmacy. Disclosure. Objectives 9/9/2015

Board of Pharmacy Legislative Update Allison M. Dudley, J.D. Executive Director Board of Pharmacy. Disclosure. Objectives 9/9/2015 Board of Pharmacy Legislative Update Allison M. Dudley, J.D. Executive Director Board of Pharmacy Disclosure I have nothing to disclose and further, I was not paid an honorarium or travel reimbursement

More information

247 CMR: BOARD OF REGISTRATION IN PHARMACY

247 CMR: BOARD OF REGISTRATION IN PHARMACY 247 CMR 9.00: CODE OF PROFESSIONAL CONDUCT; PROFESSIONAL STANDARDS FOR REGISTERED PHARMACISTS, PHARMACIES AND PHARMACY DEPART- MENTS Section 9.01: Code of Professional Conduct for Registered Pharmacists,

More information

State of South Dakota Board of Pharmacy Prescription Drug Monitoring Program. User Support Manual

State of South Dakota Board of Pharmacy Prescription Drug Monitoring Program. User Support Manual State of South Dakota Board of Pharmacy Prescription Drug Monitoring Program User Support Manual Contents 1 What Is a Requestor?... 3 2 Registration... 4 2.1 Registration Process... 4 2.2 Registering as

More information

Managed Care Program

Managed Care Program Summit Workers Compensation Managed Care Program FLORIDA How to obtain medical care for a work-related injury or illness. Welcome The Summit workers compensation managed-care arrangement (Summit MCA)

More information

Session 3 THIS INITIATIVE IS BEING SUPPORTED BY A SPONSORSHIP FROM PFIZER

Session 3 THIS INITIATIVE IS BEING SUPPORTED BY A SPONSORSHIP FROM PFIZER Session 3 THIS INITIATIVE IS BEING SUPPORTED BY A SPONSORSHIP FROM PFIZER Disclosure The Immunization Action Coalition has been responsible for all aspects of content development for the enclosed presentation

More information

For a Healthier America: Reducing Prescription Drug Misuse and Abuse

For a Healthier America: Reducing Prescription Drug Misuse and Abuse For a Healthier America: Reducing Prescription Drug Misuse and Abuse The misuse and abuse of prescription medicines is a growing public health problem. In addition to the tragic toll on families and communities,

More information

Training Guide for Data Requesters

Training Guide for Data Requesters Office of Substance Abuse and Mental Health Services Maine Department of Health and Human Services Prescription Monitoring Program October 2015 Contents Contents 1 System Overview... 1 About RxSentry and

More information

Michael D. Bullek BSP Rph. Commissioner, New Hampshire Board of Pharmacy

Michael D. Bullek BSP Rph. Commissioner, New Hampshire Board of Pharmacy Michael D. Bullek BSP Rph. Commissioner, New Hampshire Board of Pharmacy Legislative changes PDMP program changes 503B outsourcing facilities Rules changes Ph800 review Ph300 Ph400 Ph700 Current issues

More information

LEGISLATURE OF THE STATE OF IDAHO Sixty-third Legislature Second Regular Session - 2016 IN THE SENATE SENATE BILL NO. 1322

LEGISLATURE OF THE STATE OF IDAHO Sixty-third Legislature Second Regular Session - 2016 IN THE SENATE SENATE BILL NO. 1322 LEGISLATURE OF THE STATE OF IDAHO Sixty-third Legislature Second Regular Session - IN THE SENATE SENATE BILL NO. BY HEALTH AND WELFARE COMMITTEE 0 0 AN ACT RELATING TO EPINEPHRINE AUTO-INJECTORS; AMENDING

More information

Dispenser s Implementation Guide Version 1.11

Dispenser s Implementation Guide Version 1.11 Dispenser s Implementation Guide Version 1.11 Florida Department of Health Prescription Drug Monitoring Program eptember 2012 This project was supported by Grant No. 2009-PM-BX-4004 awarded by the Bureau

More information

DEA REGISTRATION FEES FACT SHEET

DEA REGISTRATION FEES FACT SHEET DEA REGISTRATION FEES FACT SHEET Summary On April 16, 2012,the Drug Enforcement Administration (DEA) will implement an adjustment to the fees it charges to DEA registrants. For the vast majority of registrants

More information

CHAPTER 10 PHARMACY TECHNICIAN REGULATIONS. These regulations are promulgated as authorized by the Act.

CHAPTER 10 PHARMACY TECHNICIAN REGULATIONS. These regulations are promulgated as authorized by the Act. CHAPTER 10 PHARMACY TECHNICIAN REGULATIONS Section 1. Authority. These regulations are promulgated as authorized by the Act. Section 2. Definitions. Direct supervision means that a licensed pharmacist

More information

Drug Diversion. Controlled Substance Prescribing and Diversion

Drug Diversion. Controlled Substance Prescribing and Diversion Drug Diversion Provider Presentation Controlled Substance Prescribing and Diversion Angela Wallace, R.Ph. Coastal District Inspector, PMP Law Enforcement Officer DHEC Bureau of Drug Control Presentation

More information

IAC 12/12/12 Pharmacy[657] Ch 5, p.1 CHAPTER 5 PHARMACY SUPPORT PERSONS

IAC 12/12/12 Pharmacy[657] Ch 5, p.1 CHAPTER 5 PHARMACY SUPPORT PERSONS IAC 12/12/12 Pharmacy[657] Ch 5, p.1 CHAPTER 5 PHARMACY SUPPORT PERSONS 657 5.1(155A) Definitions. For purposes of this chapter, the following definitions shall apply: Board means the Iowa board of pharmacy.

More information

CAPITOL research. Interstate Information Sharing: Prescription Drug Monitoring Programs

CAPITOL research. Interstate Information Sharing: Prescription Drug Monitoring Programs The Council of State governments CAPITOL research APRIL 00 Prescription Drug Monitoring Interstate Information Sharing: Prescription Drug Monitoring Programs The Council of State Governments Misuse of

More information

Prescription Drug Monitoring Program. A Powerful Tool

Prescription Drug Monitoring Program. A Powerful Tool Prescription Drug Monitoring Program A Powerful Tool September 16, 2015 No reportable financial interest. Controlled Substance Utilization Review and Evaluation System >16,000 Prescription Painkiller Overdose

More information

CRS Report for Congress

CRS Report for Congress Order Code RS22310 October 28, 2005 CRS Report for Congress Received through the CRS Web Hurricane Katrina: HIPAA Privacy and Electronic Health Records of Evacuees Summary Gina Marie Stevens Legislative

More information

RHODE ISLAND PRESCRIPTION MONITORING PROGRAM DATA COLLECTION MANUAL

RHODE ISLAND PRESCRIPTION MONITORING PROGRAM DATA COLLECTION MANUAL RHODE ISLAND PRESCRIPTION MONITORING PROGRAM DATA COLLECTION MANUAL Effective Date: October 13, 2014 Optimum Technology, Inc. Contact Information Phone: 866-683-2476 Fax: 866-282-7076 RIRxReport@otech.com

More information

PRESCRIPTION MONITORING PROGRAM STATE PROFILES LOUISIANA

PRESCRIPTION MONITORING PROGRAM STATE PROFILES LOUISIANA PRESCRIPTION MONITORING PROGRAM STATE PROFILES LOUISIANA Research current through July 2014. This project was supported by Grant No. G1399ONDCP03A, awarded by the Office of National Drug Control Policy.

More information

I-STOP: What You Need to Know. Lyuba Konopasek, MD Designated Institutional Official NewYork-Presbyterian Hospital August 26, 2013

I-STOP: What You Need to Know. Lyuba Konopasek, MD Designated Institutional Official NewYork-Presbyterian Hospital August 26, 2013 I-STOP: What You Need to Know Lyuba Konopasek, MD Designated Institutional Official NewYork-Presbyterian Hospital August 26, 2013 What is I-STOP? Objectives Why is I-STOP necessary and how is it relevant

More information

3.Prescriber DEA: 4.Board Registration Number: 5.Business Tel:

3.Prescriber DEA: 4.Board Registration Number: 5.Business Tel: Commonwealth of Massachusetts Department of Public Health, Office of Prescription Monitoring and Drug Control 99 Chauncy Street, Boston, MA 02111 Tel: 617-753-7310 Email: mapmp.dph@state.ma.us MA ONLINE

More information

EMR Technology Checklist

EMR Technology Checklist Patient Accessibility/Scheduling/Account Maintenance: Able to interact with schedule through an online portal pre register VIP status to move patient to the front of the line Access and pre registration

More information

NOTICES OF PROPOSED RULEMAKING

NOTICES OF PROPOSED RULEMAKING NOTICES OF PROPOSED RULEMAKING Unless exempted by A.R.S. 41-1005, each agency shall begin the rulemaking process by first submitting to the Secretary of State s Office a Notice of Rulemaking Docket Opening

More information

Prescription Drug Monitoring Program Center of Excellence at Brandeis

Prescription Drug Monitoring Program Center of Excellence at Brandeis Prescription Drug Monitoring Program Center of Excellence at Brandeis Notes from the Field NF 4.1 Using PDMPs to Improve Medical Care: Washington State s Data Sharing Initiative with Medicaid and Workers

More information

LOUISIANA PRESCRIPTION MONITORING PROGRAM

LOUISIANA PRESCRIPTION MONITORING PROGRAM LOUISIANA PRESCRIPTION MONITORING PROGRAM DATA COLLECTION MANUAL - VERSION 1.0 Revision History Date Version Description Author 12/13/2013 1.0 Initial version Lena Roe (Otech) 1/28/2014 1.1 Updates Lena

More information

HOUSE OF REPRESENTATIVES STAFF ANALYSIS REFERENCE ACTION ANALYST STAFF DIRECTOR

HOUSE OF REPRESENTATIVES STAFF ANALYSIS REFERENCE ACTION ANALYST STAFF DIRECTOR HOUSE OF REPRESENTATIVES STAFF ANALYSIS BILL #: HB 371 CS Cancer Drug Donation Program SPONSOR(S): Harrell TIED BILLS: IDEN./SIM. BILLS: SB 1310 REFERENCE ACTION ANALYST STAFF DIRECTOR 1) Health Care General

More information

Division II Medical/Pharmaceutical Services, Education and Oversight Sen. Carson (Thursday) 12/14/2015

Division II Medical/Pharmaceutical Services, Education and Oversight Sen. Carson (Thursday) 12/14/2015 Division II Medical/Pharmaceutical Services, Education and Oversight Carson (Thursday) 12/14/2015 Topic -Division II Expanding Board of Medicine; including practitioner of pain medicine or anesthesiology

More information